Form 8-K Skye Bioscience, Inc. For: Oct 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall St set to open higher as pause in US-Iran hostilities lifts sentiment
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices near one-week low after US, Iran pause fighting over weekend
- Jefferies turns bullish on Ford, GM ahead of earnings, citing stronger margins
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- Taiwan Semi (TSM) PT Raised to $530 at Needham
- Strategy sells MSTR shares, doesn't buy bitcoin
Craig-Hallum Downgrades Skye Bioscience (SKYE) to Hold
October 6, 2025 12:11 PM EDTCraig-Hallum analyst Albert Lowe downgraded Skye Bioscience (NASDAQ: SKYE) from Buy to Hold with a price target of $2.00.
For an analyst ratings summary and ratings history on Skye Bioscience click here. For more ratings news on Skye Bioscience click here.
Shares of Skye Bioscience closed at $4.75 yesterday.
... More